Sponsored Post As Healthcare and Biopharma Companies Embrace AI, Insurance Underwriters See Risks and Opportunities By Stephanie Baum
BioPharma FDA Approves Abeona Gene Therapy for Healing Wounds From Rare, Inherited Skin Disease By Frank Vinluan
Consumer / Employer Is Glen Tullman a Hypocrite or a Victim of the System He Aimed to Disrupt? By Arundhati Parmar
Devices & Diagnostics DexCom’s CEO Believes Diabetics On GLP-1s Should Also Wear CGMs By Arundhati Parmar
BioPharma, Legal The 4 Biotech Companies on Track to IPO this Week Despite the Government Shutdown By Frank Vinluan
BioPharma, Pharma Clinical Trial Holds Cast Doubt on Approval Chances of Regenxbio Gene Therapy for Rare Disease By Frank Vinluan
MedCity Influencers Harnessing RWE for Post-Pandemic Healthcare: Accelerating Drug Development with Real-World Data By Christopher McSpiritt
BioPharma, Pharma Fatal Complication of Stem Cell Transplants Gets Its First FDA-Approved Therapy By Frank Vinluan
Sponsored Post 5 Places to Find Affordable Partial Hospitalization Programs in Brookline By Bournewood Health Systems
MedCity Influencers The Referral Is Broken: Why Healthcare’s Last Bottleneck Still Lacks Innovation By Naheem Noah
